(S)-1-(4-(4-METHYLTHIAZOL-5-YL)PHENYL)ETHAN-1-AMINE HCL, 95.0%, 5g

2-Bromo-3-nitrobenzonitrile, 97%, 100mg

(S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride, 97.0%, 5g

TERT-BUTYL 3-BENZYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBOXYLATE, 95.0%, 25g

N-(Piperidin-4-ylmethyl)-2-(trifluoromethyl)-1,6-naphthyridin-5-amine hydrochloride hydrate, 95.0%, 5g

3-Nitrobenzonitrile, min. 98%, for synthesis, 25 g, glass packaging

Ethyl 4-oxo-3-(propionyloxy)-4H-pyran-2-carboxylate, 97.0%, 10g

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanehydrazide, 95.0%, 5g

3-(1-Methyl-1H-pyrazol-4-yl)-1-p-tolyl-propenone, 250mg

(S)-2-AMINO-3,N-DIPHENYLPROPANAMIDE, 97.0%, 1g

2-((5-CHLORO-2-((4-(PIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)-N-METHYLBENZAMIDE, 95%, 50mg

N-Boc-L-Allothreonine, 95.0%, 5g

trans-4-methoxytetrahydro-2H-pyran-3-amine hydrochloride, 95.0%, 250mg